nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—ABCB1—Lisinopril—dilated cardiomyopathy	0.229	0.532	CbGbCtD
Clobazam—ABCB1—Spironolactone—dilated cardiomyopathy	0.202	0.468	CbGbCtD
Clobazam—Appetite absent—Lisinopril—dilated cardiomyopathy	0.0124	0.0265	CcSEcCtD
Clobazam—Apathy—Furosemide—dilated cardiomyopathy	0.0115	0.0246	CcSEcCtD
Clobazam—Flat affect—Furosemide—dilated cardiomyopathy	0.0114	0.0243	CcSEcCtD
Clobazam—Lethargy—Spironolactone—dilated cardiomyopathy	0.0112	0.0239	CcSEcCtD
Clobazam—Ataxia—Spironolactone—dilated cardiomyopathy	0.0103	0.022	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00988	0.0211	CcSEcCtD
Clobazam—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00939	0.02	CcSEcCtD
Clobazam—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00845	0.018	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00838	0.0179	CcSEcCtD
Clobazam—Oxcarbazepine—SCN5A—dilated cardiomyopathy	0.00722	0.835	CrCbGaD
Clobazam—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00718	0.0153	CcSEcCtD
Clobazam—SLC6A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00664	0.0724	CbGpPWpGaD
Clobazam—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00635	0.0136	CcSEcCtD
Clobazam—Lethargy—Furosemide—dilated cardiomyopathy	0.00609	0.013	CcSEcCtD
Clobazam—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00591	0.0126	CcSEcCtD
Clobazam—Irritability—Furosemide—dilated cardiomyopathy	0.0057	0.0122	CcSEcCtD
Clobazam—Confusional state—Spironolactone—dilated cardiomyopathy	0.00544	0.0116	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00537	0.0115	CcSEcCtD
Clobazam—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00535	0.0584	CbGpPWpGaD
Clobazam—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00528	0.0113	CcSEcCtD
Clobazam—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00526	0.0112	CcSEcCtD
Clobazam—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00519	0.0111	CcSEcCtD
Clobazam—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00511	0.0109	CcSEcCtD
Clobazam—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00483	0.0103	CcSEcCtD
Clobazam—Somnolence—Spironolactone—dilated cardiomyopathy	0.00479	0.0102	CcSEcCtD
Clobazam—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00465	0.00993	CcSEcCtD
Clobazam—Drowsiness—Furosemide—dilated cardiomyopathy	0.0046	0.00982	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00456	0.00973	CcSEcCtD
Clobazam—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00448	0.00956	CcSEcCtD
Clobazam—Diplopia—Lisinopril—dilated cardiomyopathy	0.00448	0.00956	CcSEcCtD
Clobazam—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00444	0.00948	CcSEcCtD
Clobazam—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00444	0.00948	CcSEcCtD
Clobazam—Sweating—Furosemide—dilated cardiomyopathy	0.00441	0.00941	CcSEcCtD
Clobazam—Urticaria—Spironolactone—dilated cardiomyopathy	0.00428	0.00914	CcSEcCtD
Clobazam—Irritability—Lisinopril—dilated cardiomyopathy	0.00427	0.00912	CcSEcCtD
Clobazam—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00426	0.0091	CcSEcCtD
Clobazam—Ataxia—Lisinopril—dilated cardiomyopathy	0.00421	0.00899	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00403	0.00861	CcSEcCtD
Clobazam—Visual impairment—Furosemide—dilated cardiomyopathy	0.00398	0.00849	CcSEcCtD
Clobazam—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0039	0.00833	CcSEcCtD
Clobazam—Asthma—Lisinopril—dilated cardiomyopathy	0.00387	0.00826	CcSEcCtD
Clobazam—Eye disorder—Furosemide—dilated cardiomyopathy	0.00386	0.00824	CcSEcCtD
Clobazam—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00383	0.00818	CcSEcCtD
Clobazam—Pruritus—Spironolactone—dilated cardiomyopathy	0.00381	0.00814	CcSEcCtD
Clobazam—SLC6A1—Monoamine Transport—AGT—dilated cardiomyopathy	0.0038	0.0414	CbGpPWpGaD
Clobazam—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00372	0.00794	CcSEcCtD
Clobazam—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00369	0.00787	CcSEcCtD
Clobazam—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.0036	0.00768	CcSEcCtD
Clobazam—Malnutrition—Furosemide—dilated cardiomyopathy	0.00359	0.00767	CcSEcCtD
Clobazam—Dizziness—Spironolactone—dilated cardiomyopathy	0.00357	0.00761	CcSEcCtD
Clobazam—Weight increased—Lisinopril—dilated cardiomyopathy	0.00352	0.00752	CcSEcCtD
Clobazam—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00347	0.00741	CcSEcCtD
Clobazam—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00346	0.00738	CcSEcCtD
Clobazam—Depression—Lisinopril—dilated cardiomyopathy	0.00344	0.00734	CcSEcCtD
Clobazam—Vomiting—Spironolactone—dilated cardiomyopathy	0.00343	0.00732	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00342	0.0073	CcSEcCtD
Clobazam—Rash—Spironolactone—dilated cardiomyopathy	0.0034	0.00726	CcSEcCtD
Clobazam—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0034	0.00725	CcSEcCtD
Clobazam—Vision blurred—Furosemide—dilated cardiomyopathy	0.00339	0.00723	CcSEcCtD
Clobazam—Headache—Spironolactone—dilated cardiomyopathy	0.00338	0.00721	CcSEcCtD
Clobazam—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00335	0.00716	CcSEcCtD
Clobazam—Anaemia—Furosemide—dilated cardiomyopathy	0.00332	0.00709	CcSEcCtD
Clobazam—SLC6A11—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00332	0.0362	CbGpPWpGaD
Clobazam—Sweating—Lisinopril—dilated cardiomyopathy	0.00331	0.00706	CcSEcCtD
Clobazam—Agitation—Furosemide—dilated cardiomyopathy	0.0033	0.00705	CcSEcCtD
Clobazam—Leukopenia—Furosemide—dilated cardiomyopathy	0.00322	0.00687	CcSEcCtD
Clobazam—Nausea—Spironolactone—dilated cardiomyopathy	0.0032	0.00684	CcSEcCtD
Clobazam—Hallucination—Lisinopril—dilated cardiomyopathy	0.00308	0.00658	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00304	0.00649	CcSEcCtD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00302	0.0329	CbGpPWpGaD
Clobazam—Dry mouth—Furosemide—dilated cardiomyopathy	0.00299	0.00639	CcSEcCtD
Clobazam—Confusional state—Furosemide—dilated cardiomyopathy	0.00296	0.00631	CcSEcCtD
Clobazam—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00293	0.00625	CcSEcCtD
Clobazam—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00288	0.00614	CcSEcCtD
Clobazam—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00287	0.00613	CcSEcCtD
Clobazam—Skin disorder—Furosemide—dilated cardiomyopathy	0.00285	0.00608	CcSEcCtD
Clobazam—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00284	0.00605	CcSEcCtD
Clobazam—Anorexia—Furosemide—dilated cardiomyopathy	0.0028	0.00597	CcSEcCtD
Clobazam—Hypotension—Furosemide—dilated cardiomyopathy	0.00274	0.00585	CcSEcCtD
Clobazam—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00271	0.00579	CcSEcCtD
Clobazam—Malnutrition—Lisinopril—dilated cardiomyopathy	0.0027	0.00576	CcSEcCtD
Clobazam—SLC6A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00267	0.0292	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—ABCC9—dilated cardiomyopathy	0.00265	0.0289	CbGpPWpGaD
Clobazam—Tension—Lisinopril—dilated cardiomyopathy	0.00265	0.00565	CcSEcCtD
Clobazam—Nervousness—Lisinopril—dilated cardiomyopathy	0.00262	0.00559	CcSEcCtD
Clobazam—Somnolence—Furosemide—dilated cardiomyopathy	0.00261	0.00557	CcSEcCtD
Clobazam—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00259	0.00553	CcSEcCtD
Clobazam—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00255	0.00544	CcSEcCtD
Clobazam—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00254	0.00542	CcSEcCtD
Clobazam—SLC6A11—Neuronal System—ACTN2—dilated cardiomyopathy	0.00254	0.0277	CbGpPWpGaD
Clobazam—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00253	0.00541	CcSEcCtD
Clobazam—Fatigue—Furosemide—dilated cardiomyopathy	0.00253	0.0054	CcSEcCtD
Clobazam—Tremor—Lisinopril—dilated cardiomyopathy	0.00253	0.00539	CcSEcCtD
Clobazam—Constipation—Furosemide—dilated cardiomyopathy	0.00251	0.00535	CcSEcCtD
Clobazam—Anaemia—Lisinopril—dilated cardiomyopathy	0.00249	0.00532	CcSEcCtD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00243	0.0265	CbGpPWpGaD
Clobazam—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00242	0.00516	CcSEcCtD
Clobazam—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00241	0.00515	CcSEcCtD
Clobazam—Cough—Lisinopril—dilated cardiomyopathy	0.00235	0.00502	CcSEcCtD
Clobazam—Urticaria—Furosemide—dilated cardiomyopathy	0.00233	0.00497	CcSEcCtD
Clobazam—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00232	0.00495	CcSEcCtD
Clobazam—Myalgia—Lisinopril—dilated cardiomyopathy	0.0023	0.0049	CcSEcCtD
Clobazam—Anxiety—Lisinopril—dilated cardiomyopathy	0.00229	0.00488	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00228	0.00487	CcSEcCtD
Clobazam—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00225	0.00479	CcSEcCtD
Clobazam—Confusional state—Lisinopril—dilated cardiomyopathy	0.00222	0.00474	CcSEcCtD
Clobazam—Infection—Lisinopril—dilated cardiomyopathy	0.00219	0.00467	CcSEcCtD
Clobazam—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00215	0.0046	CcSEcCtD
Clobazam—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00214	0.00456	CcSEcCtD
Clobazam—SLC6A1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00214	0.0233	CbGpPWpGaD
Clobazam—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00213	0.00454	CcSEcCtD
Clobazam—Asthenia—Furosemide—dilated cardiomyopathy	0.0021	0.00449	CcSEcCtD
Clobazam—Anorexia—Lisinopril—dilated cardiomyopathy	0.0021	0.00448	CcSEcCtD
Clobazam—Pruritus—Furosemide—dilated cardiomyopathy	0.00208	0.00443	CcSEcCtD
Clobazam—Hypotension—Lisinopril—dilated cardiomyopathy	0.00206	0.00439	CcSEcCtD
Clobazam—SLC6A1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00205	0.0223	CbGpPWpGaD
Clobazam—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00201	0.00428	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00201	0.00428	CcSEcCtD
Clobazam—Insomnia—Lisinopril—dilated cardiomyopathy	0.00199	0.00425	CcSEcCtD
Clobazam—Somnolence—Lisinopril—dilated cardiomyopathy	0.00196	0.00418	CcSEcCtD
Clobazam—Dizziness—Furosemide—dilated cardiomyopathy	0.00194	0.00414	CcSEcCtD
Clobazam—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00191	0.00408	CcSEcCtD
Clobazam—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.0019	0.00406	CcSEcCtD
Clobazam—Fatigue—Lisinopril—dilated cardiomyopathy	0.0019	0.00405	CcSEcCtD
Clobazam—Constipation—Lisinopril—dilated cardiomyopathy	0.00188	0.00402	CcSEcCtD
Clobazam—Vomiting—Furosemide—dilated cardiomyopathy	0.00187	0.00398	CcSEcCtD
Clobazam—Rash—Furosemide—dilated cardiomyopathy	0.00185	0.00395	CcSEcCtD
Clobazam—Dermatitis—Furosemide—dilated cardiomyopathy	0.00185	0.00394	CcSEcCtD
Clobazam—Headache—Furosemide—dilated cardiomyopathy	0.00184	0.00392	CcSEcCtD
Clobazam—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00181	0.00387	CcSEcCtD
Clobazam—Urticaria—Lisinopril—dilated cardiomyopathy	0.00175	0.00373	CcSEcCtD
Clobazam—Nausea—Furosemide—dilated cardiomyopathy	0.00174	0.00372	CcSEcCtD
Clobazam—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00174	0.00371	CcSEcCtD
Clobazam—SLC6A1—Monoamine Transport—TNF—dilated cardiomyopathy	0.00172	0.0188	CbGpPWpGaD
Clobazam—Asthenia—Lisinopril—dilated cardiomyopathy	0.00158	0.00337	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00158	0.0172	CbGpPWpGaD
Clobazam—Pruritus—Lisinopril—dilated cardiomyopathy	0.00156	0.00332	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00153	0.0167	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00153	0.0167	CbGpPWpGaD
Clobazam—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00151	0.00321	CcSEcCtD
Clobazam—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00149	0.0163	CbGpPWpGaD
Clobazam—Dizziness—Lisinopril—dilated cardiomyopathy	0.00146	0.00311	CcSEcCtD
Clobazam—Loxapine—ADRB1—dilated cardiomyopathy	0.00143	0.166	CrCbGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00143	0.0156	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00142	0.0155	CbGpPWpGaD
Clobazam—Vomiting—Lisinopril—dilated cardiomyopathy	0.0014	0.00299	CcSEcCtD
Clobazam—Rash—Lisinopril—dilated cardiomyopathy	0.00139	0.00296	CcSEcCtD
Clobazam—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00139	0.00296	CcSEcCtD
Clobazam—Headache—Lisinopril—dilated cardiomyopathy	0.00138	0.00294	CcSEcCtD
Clobazam—Nausea—Lisinopril—dilated cardiomyopathy	0.00131	0.00279	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00127	0.0139	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00124	0.0135	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00124	0.0135	CbGpPWpGaD
Clobazam—GABRB2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00124	0.0135	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0012	0.0131	CbGpPWpGaD
Clobazam—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	0.0012	0.0131	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00115	0.0125	CbGpPWpGaD
Clobazam—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00113	0.0123	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0011	0.012	CbGpPWpGaD
Clobazam—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.0011	0.012	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—ANKRD1—dilated cardiomyopathy	0.00104	0.0113	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00102	0.0111	CbGpPWpGaD
Clobazam—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.000987	0.0108	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—TAZ—dilated cardiomyopathy	0.000974	0.0106	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000962	0.0105	CbGpPWpGaD
Clobazam—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00096	0.0105	CbGpPWpGaD
Clobazam—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00095	0.0104	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000905	0.00987	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—SDHA—dilated cardiomyopathy	0.000881	0.00961	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000827	0.00903	CbGpPWpGaD
Clobazam—SLC6A11—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000754	0.00823	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000723	0.00789	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000723	0.00789	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000693	0.00756	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000661	0.00722	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000634	0.00692	CbGpPWpGaD
Clobazam—SLC6A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000608	0.00664	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000578	0.00631	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—RAF1—dilated cardiomyopathy	0.000578	0.00631	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000554	0.00605	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—RAF1—dilated cardiomyopathy	0.000466	0.00508	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00043	0.00469	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000422	0.00461	CbGpPWpGaD
Clobazam—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000421	0.0046	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000418	0.00456	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000418	0.00456	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000397	0.00434	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000393	0.00429	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000389	0.00424	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000382	0.00417	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000382	0.00417	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000356	0.00388	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000355	0.00388	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000344	0.00376	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000344	0.00375	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000334	0.00365	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000334	0.00365	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—ANKRD1—dilated cardiomyopathy	0.000312	0.00341	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000311	0.00339	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000311	0.00339	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000298	0.00325	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—TAZ—dilated cardiomyopathy	0.000294	0.00321	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000277	0.00302	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000274	0.00299	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000267	0.00291	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—SDHA—dilated cardiomyopathy	0.000266	0.0029	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000261	0.00284	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000251	0.00273	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00025	0.00273	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000245	0.00267	CbGpPWpGaD
Clobazam—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000244	0.00266	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—GPX1—dilated cardiomyopathy	0.000239	0.00261	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CD36—dilated cardiomyopathy	0.000233	0.00254	CbGpPWpGaD
Clobazam—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000223	0.00243	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000219	0.00239	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—AGT—dilated cardiomyopathy	0.00021	0.00229	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000206	0.00225	CbGpPWpGaD
Clobazam—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000195	0.00213	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000188	0.00205	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000172	0.00188	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000168	0.00183	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000168	0.00183	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000165	0.0018	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000158	0.00172	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000156	0.0017	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000154	0.00168	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	0.000144	0.00158	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000144	0.00157	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000137	0.00149	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000132	0.00144	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000131	0.00143	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000131	0.00143	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000129	0.00141	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000126	0.00138	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000116	0.00127	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000113	0.00124	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000113	0.00124	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000109	0.00119	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000107	0.00116	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	9.87e-05	0.00108	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	9.63e-05	0.00105	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	8.56e-05	0.000935	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.48e-05	0.000925	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.76e-05	0.000846	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GPX1—dilated cardiomyopathy	7.22e-05	0.000788	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CD36—dilated cardiomyopathy	7.03e-05	0.000767	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	6.98e-05	0.000762	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.78e-05	0.00074	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	6.56e-05	0.000716	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—AGT—dilated cardiomyopathy	6.33e-05	0.000691	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.02e-05	0.000657	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	5.94e-05	0.000648	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	5.87e-05	0.000641	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.86e-05	0.00064	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	5.59e-05	0.00061	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.28e-05	0.000576	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	3.55e-05	0.000387	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	3.46e-05	0.000377	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.4e-05	0.000371	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	3.11e-05	0.00034	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	2.68e-05	0.000293	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.62e-05	0.000286	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	2.61e-05	0.000285	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.55e-05	0.000278	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.35e-05	0.000257	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.29e-05	0.00025	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.61e-05	0.000176	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.57e-05	0.000171	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.41e-05	0.000154	CbGpPWpGaD
